Zobrazeno 1 - 10
of 446
pro vyhledávání: '"Kanebratt KP"'
Autor:
Arjmandi H; Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom., Kanebratt KP; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gothenburg, Sweden., Vilén L; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gothenburg, Sweden., Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Noel A; School of Engineering, University of Warwick, Coventry, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2024 Sep 12; Vol. 19 (9), pp. e0310109. Date of Electronic Publication: 2024 Sep 12 (Print Publication: 2024).
Autor:
Rigal S; TissUse GmbH, Berlin, Germany., Casas B; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Kanebratt KP; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wennberg Huldt C; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Magnusson LU; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Müllers E; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Karlsson F; Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Clausen M; Translational Genomics, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Hansson SF; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Leonard L; Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Cairns J; Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Jansson Löfmark R; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ämmälä C; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Marx U; TissUse GmbH, Berlin, Germany., Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Cedersund G; Department of Biomedical Engineering, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden., Andersson TB; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Vilén LK; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. liisa.vilen@astrazeneca.com.; Division of Pharmaceutical Biosciences, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland. liisa.vilen@astrazeneca.com.
Publikováno v:
Communications biology [Commun Biol] 2024 Jul 18; Vol. 7 (1), pp. 877. Date of Electronic Publication: 2024 Jul 18.
Autor:
Casas B; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Vilén L; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bauer S; TissUse GmbH, Berlin, Germany., Kanebratt KP; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wennberg Huldt C; Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Magnusson L; Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Marx U; TissUse GmbH, Berlin, Germany., Andersson TB; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Cedersund G; Department of Biomedical Engineering, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.
Publikováno v:
PLoS computational biology [PLoS Comput Biol] 2022 Oct 19; Vol. 18 (10), pp. e1010587. Date of Electronic Publication: 2022 Oct 19 (Print Publication: 2022).
Autor:
Guo, Kaidi1 (AUTHOR) k.guo@maastrichtuniversity.nl, van den Beucken, Twan1 (AUTHOR)
Publikováno v:
Cell & Bioscience. 11/2/2024, Vol. 14 Issue 1, p1-20. 20p.
Autor:
Kanebratt KP; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden. Electronic address: kajsa.p.kanebratt@astrazeneca.com., Janefeldt A; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Vilén L; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Vildhede A; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Samuelsson K; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Milton L; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Björkbom A; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Persson M; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Leandersson C; Physical & Analytical Chemistry, Research and Early Development Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Andersson TB; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Hilgendorf C; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2021 Jan; Vol. 110 (1), pp. 422-431. Date of Electronic Publication: 2020 Oct 26.
Autor:
Rabiet, Lucile1,2 (AUTHOR) lucile.rabiet@gmail.com, Jeger-Madiot, Nathan1 (AUTHOR), García, Duván Rojas1 (AUTHOR), Tosca, Lucie3 (AUTHOR), Tachdjian, Gérard3 (AUTHOR), Kellouche, Sabrina4 (AUTHOR), Agniel, Rémy4 (AUTHOR), Larghero, Jérôme2 (AUTHOR), Aider, Jean-Luc1 (AUTHOR) jean-luc.aider@espci.psl.eu, Arakelian, Lousineh2 (AUTHOR) lousineh.arakelian@aphp.fr
Publikováno v:
Scientific Reports. 9/14/2024, Vol. 14 Issue 1, p1-11. 11p.
Autor:
Yunjia Lai1, Ay, Muhammet2, Carolina Duarte Hospital1, Miller, Gary W.1, Sarkar, Souvarish2,3 souvarish_sarkar@urmc.rochester.edu
Publikováno v:
Environmental Health Perspectives. Sep2024, Vol. 132 Issue 9, p094201-1-094201-12. 12p.
Autor:
Kumondai, Masaki1 masaki.kumondai.d5@tohoku.ac.jp, Ogawa, Reika1, Hayashi, Nagomi2, Ishida, Yurika1, Oshikiri, Hanae1, Sato, Yuji1, Kikuchi, Masafumi1,2, Sato, Yu1, Sato, Toshihiro1, Maekawa, Masamitsu1,2, Mano, Nariyasu1,2
Publikováno v:
Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-11. 11p.
Autor:
Hosseinzadeh, Mahdieh1,2, Saber, Niloufar3, Bidar, Sakineh Shab4, Hashemi, Sogol3, Teymoori, Farshad3,5, Mirzaei, Masoud6, Nadjarzadeh, Azadeh1,2, Rahideh, Seyedeh Tayebeh3 rahide.t@iums.ac.ir
Publikováno v:
BMC Endocrine Disorders. 8/1/2024, Vol. 24 Issue 1, p1-12. 12p.
Autor:
Mickols, Evgeniya1 (AUTHOR), Meyer, Alina1 (AUTHOR), Handin, Niklas1 (AUTHOR), Stüwe, Malin1 (AUTHOR), Eriksson, Jens2 (AUTHOR), Rudfeldt, Jakob3 (AUTHOR), Blom, Kristin3 (AUTHOR), Fryknäs, Mårten3 (AUTHOR), Sellin, Mikael E.2 (AUTHOR), Lauschke, Volker M.4,5,6,7 (AUTHOR), Karlgren, Maria1 (AUTHOR), Artursson, Per1 (AUTHOR) Per.Artursson@farmaci.uu.se
Publikováno v:
Scientific Reports. 7/27/2024, Vol. 14 Issue 1, p1-13. 13p.